These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32947189)

  • 1. Gradient HPLC-DAD method for quantification of novel oral anticoagulant "Edoxaban" in plasma: Its selective determination in presence of sixteen co-administered drugs.
    Younis SE; El-Nahass SA; Elkhatib MAW; Soliman SA; Youssef RM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122386. PubMed ID: 32947189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.
    Gouveia F; Bicker J; Santos J; Rocha M; Alves G; Falcão A; Fortuna A
    J Pharm Biomed Anal; 2020 Mar; 181():113109. PubMed ID: 31981828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasma.
    Ariizumi S; Naito T; Hoshikawa K; Akutsu S; Saotome M; Maekawa Y; Kawakami J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1146():122121. PubMed ID: 32361632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies.
    Zhao Y; Couchman L; Kipper K; Arya R; Patel JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122095. PubMed ID: 32251991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
    Eikelboom JW; Quinlan DJ; Hirsh J; Connolly SJ; Weitz JI
    JAMA Cardiol; 2017 May; 2(5):566-574. PubMed ID: 28355459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of capillary zone electrophoresis and high-performance liquid chromatography methods for the determination of oral anticoagulant edoxaban in pharmaceutical tablets.
    Oliveira Rocha M; Bordignon Primieri G; Ribeiro Wingert N; Arguello Da Silva J; Steppe M
    Electrophoresis; 2022 Aug; 43(15):1617-1625. PubMed ID: 35507637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.
    Yamazaki-Nishioka M; Kogiku M; Noda M; Endo S; Takekawa M; Kishi H; Ota M; Notsu Y; Shimizu M; Yamazaki H
    Xenobiotica; 2019 Sep; 49(9):1001-1006. PubMed ID: 30216091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC-MS/MS method.
    Zhang WL; Lou D; Zhang DT; Zhang Y; Huang HJ
    J Thromb Thrombolysis; 2016 Aug; 42(2):205-11. PubMed ID: 27116356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.
    Wiesen MHJ; Blaich C; Streichert T; Michels G; Müller C
    Clin Chem Lab Med; 2017 Aug; 55(9):1349-1359. PubMed ID: 28328524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD.
    Zayed A; Babaresh WM; Darweesh RS; El-Elimat T
    Acta Pharm; 2020 Sep; 70(3):343-357. PubMed ID: 32074068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative LC/MSMS method for determination of edoxaban, a Xa inhibitor and its pharmacokinetic application in patients after total knee arthroplasty.
    Hanada K; Matsumoto SI; Shibata S; Matsubara H; Tsukimura Y; Takahashi H
    Biomed Chromatogr; 2018 Jun; 32(6):e4213. PubMed ID: 29451685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New HPLC-MS method for rapid and simultaneous quantification of doxycycline, diethylcarbamazine and albendazole metabolites in rat plasma and organs after concomitant oral administration.
    Permana AD; Tekko IA; McCarthy HO; Donnelly RF
    J Pharm Biomed Anal; 2019 Jun; 170():243-253. PubMed ID: 30947125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
    Baker MM; Hammad SF; Belal TS
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma.
    Nannetti G; Pagni S; Palù G; Loregian A
    Biomed Chromatogr; 2018 Nov; 32(11):e4333. PubMed ID: 29978912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
    Lindahl S; Dyrkorn R; Spigset O; Hegstad S
    Ther Drug Monit; 2018 Jun; 40(3):369-376. PubMed ID: 29578938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HPLC-MS/MS method for simultaneous determination of the active metabolites of febuxostat (67M-1, 67M-2 and 67M-4) in human plasma.
    Xie H; Wang Z; Deng K; Jiang X; Wang L; Lv G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():24-30. PubMed ID: 25222745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.
    Morishima Y; Kamisato C; Honda Y
    Eur J Pharmacol; 2014 Nov; 742():15-21. PubMed ID: 25179572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor.
    Mendell J; Lee F; Chen S; Worland V; Shi M; Samama MM
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):212-21. PubMed ID: 23615159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.
    Gous T; Couchman L; Patel JP; Paradzai C; Arya R; Flanagan RJ
    Ther Drug Monit; 2014 Oct; 36(5):597-605. PubMed ID: 24695356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics.
    Al-Ghobashy MA; Kamal SM; El-Sayed GM; Attia AK; Nagy M; ElZeiny A; Elrakaiby MT; Nooh MM; Abbassi M; Aziz RK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():489-498. PubMed ID: 30008305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.